NF‐κB and stat3 transcription factor signatures differentiate HPV‐positive and HPV‐negative head and neck squamous cell carcinoma
Open Access
- 9 April 2015
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 137 (8) , 1879-1889
Abstract
Using high‐throughput analyses and the TRANSFAC database, we characterized TF signatures of head and neck squamous cell carcinoma (HNSCC) subgroups by inferential analysis of target gene expression, correcting for the effects of DNA methylation and copy number. Using this discovery pipeline, we determined that human papillomavirus‐related (HPV+) and HPV− HNSCC differed significantly based on the activity levels of key TFs including AP1, STATs, NF‐κB and p53. Immunohistochemical analysis confirmed that HPV− HNSCC is characterized by co‐activated STAT3 and NF‐κB pathways and functional studies demonstrate that this phenotype can be effectively targeted with combined anti‐NF‐κB and anti‐STAT therapies. These discoveries correlate strongly with previous findings connecting STATs, NF‐κB and AP1 in HNSCC. We identified five top‐scoring pair biomarkers from STATs, NF‐κB and AP1 pathways that distinguish HPV+ from HPV− HNSCC based on TF activity and validated these biomarkers on TCGA and on independent validation cohorts. We conclude that a novel approach to TF pathway analysis can provide insight into therapeutic targeting of patient subgroup for heterogeneous disease such as HNSCC.Keywords
Funding Information
- American Head and Neck Society (AHNS) (306481)
- NIDCR/NIH Challenge Grant (RC1DE020324, R01 DE013152)
- NIDCR/NCI (P50DE019032)
- NIH/NLM (R01 LM011000)
This publication has 51 references indexed in Scilit:
- Activation of the NOTCH Pathway in Head and Neck CancerCancer Research, 2014
- Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive BiomarkersCancer Discovery, 2013
- Mutant p53: one name, many proteinsGenes & Development, 2012
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- TP53Mutations and Survival in Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2007
- Simvastatin inhibits IFN-γ-induced CD40 gene expression by suppressing STAT-1αJournal of Leukocyte Biology, 2007
- Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-κB and other signal transcription factors in head and neck squamous cell carcinomaGenome Biology, 2007
- Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable PrognosisJournal of Clinical Oncology, 2006
- Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activityMolecular Cancer Therapeutics, 2004
- Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma linesInternational Journal of Cancer, 2002